Back
SAB Biotherapeutics, Inc. Stock Price Chart
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist Now
Buy
71
SABS
SAB Biotherapeutics, Inc.
Last Price:
$3.54
Seasonality Move:
-14.12%
7 Day Trial
ALL ACCESS PASS
$
7
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now-
The current trend is moderately bearish and SABS is experiencing slight buying pressure.
SAB Biotherapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.85 | Buy |
| 20-day SMA: | 3.66 | Buy |
| 50-day SMA: | 3.04 | Buy |
| 200-day SMA: | 2.18 | Buy |
| 8-day EMA: | 3.83 | Buy |
| 20-day EMA: | 3.65 | Buy |
| 50-day EMA: | 3.21 | Buy |
| 200-day EMA: | 2.66 | Buy |
SAB Biotherapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 64.23 | Buy |
| Chaikin Money Flow: | 134597 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.24 - 3.9) | Buy |
| Bollinger Bands (100): | (2.03 - 3.27) | Buy |
SAB Biotherapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for SAB Biotherapeutics, Inc. Stock
Is SAB Biotherapeutics, Inc. Stock a Buy?
-
SAB Biotherapeutics, Inc. share price is 3.98 while SABS 8-day simple moving average is 3.85, which is a Buy signal.
-
The stock price of SABS is 3.98 while SAB Biotherapeutics, Inc. 20-day SMA is 3.66, which makes it a Buy.
-
SAB Biotherapeutics, Inc. 50-day simple moving average is 3.04 while SABS share price is 3.98, making it a Buy technically.
-
SABS stock price is 3.98 and SAB Biotherapeutics, Inc. 200-day simple moving average is 2.18, creating a Buy signal.
SABS Technical Analysis vs Fundamental Analysis
Buy
71
SAB Biotherapeutics, Inc. (SABS)
is a Buy
Is SAB Biotherapeutics, Inc. a Buy or a Sell?
-
SAB Biotherapeutics, Inc. stock is rated a BuyThe current SAB Biotherapeutics, Inc. [SABS] share price is $3.98. The Score for SABS is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
SAB Biotherapeutics, Inc. Stock Info
Market Cap:
189.5M
Price in USD:
3.98
Share Volume:
505.9K
SAB Biotherapeutics, Inc. 52-Week Range
52-Week High:
6.60
52-Week Low:
1.00
Buy
71
SAB Biotherapeutics, Inc. (SABS)
is a Buy
SAB Biotherapeutics, Inc. Share Price Forecast
-
What is the SAB Biotherapeutics, Inc. stock price today?The SAB Biotherapeutics, Inc. stock price is 3.98 USD today.
-
Will SABS stock go up or go down?SAB Biotherapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is SAB Biotherapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, SAB Biotherapeutics, Inc. is not overvalued.
Is SAB Biotherapeutics, Inc. Stock a Buy?
-
SAB Biotherapeutics, Inc. share price is 3.98 while SABS 8-day exponential moving average is 3.83, which is a Buy signal.
-
The stock price of SABS is 3.98 while SAB Biotherapeutics, Inc. 20-day EMA is 3.65, which makes it a Buy.
-
SAB Biotherapeutics, Inc. 50-day exponential moving average is 3.21 while SABS share price is 3.98, making it a Buy technically.
-
SABS stock price is 3.98 and SAB Biotherapeutics, Inc. 200-day simple moving average is 2.66, creating a Buy signal.
Fundamental Analysis of SAB Biotherapeutics, Inc.
Is SAB Biotherapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.64 per share, and an increase next year of $0.70 per share.
Technical Analysis of SAB Biotherapeutics, Inc.
Should I short SAB Biotherapeutics, Inc. stock?
-
SABS Moving Average Covergence Divergence (MACD) indicator is 0.23, suggesting SAB Biotherapeutics, Inc. is a Buy
-
SAB Biotherapeutics, Inc. Relative Strength Index (RSI) is 64.23, which suggest SAB Biotherapeutics, Inc. is overbought
-
The Bollinger Bands (25) for SAB Biotherapeutics, Inc. is (3.24 - 3.9), which suggest SAB Biotherapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for SAB Biotherapeutics, Inc. is (2.03 - 3.27), which suggest SAB Biotherapeutics, Inc. is a Buy
* SAB Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.